NAN · ASX

Nanosonics Limited (ASX:NAN)

AU$4.47

 -0.26 (-5.497%)
ASX:Live
27/08/2025 04:10:25 PM
Recent Price downgrade Recent Earnings downgrade HALO Small HALO Ords HALO Balance Sheet +6
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

NAN Overview

NAN Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Very Strong

Valuation

Value

Consensus

Momentum

Price

Neutral

Earnings

Strong

Growth

Earnings

Strong

Dividends

Very Strong

Quality

Capital Efficiency

Neutral

Balance Sheet

Very Weak

About NAN

Website

Nanosonics Limited

Telephone

61.2.8063.1600

Address

Building A, Level 1 7-11 Talavera Road Macquarie Park Sydney, New South Wales (NSW) 2113

Description

Nanosonics Ltd. engages in the provision of research, development, and commercialization of infection control and decontamination products and related technologies. It operates through the following geographical segments: North America, Europe and Middle East, and Asia Pacific. Its products include trophon EPR, trophon technology, and trophon2. The company was founded by Maurie Stang on November 14, 2000 and is headquartered in Sydney, Australia.

NAN Price Chart

Key Stats

Market Cap

AU$1.44B

PE

73.70

EV/EBITDA

46.7

Dividends Overview

DIV Yield

.0%

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 2.86 - 5.18

Trade Value (12mth)

AU$816,974.00

1 week

15.37%

1 month

22.86%

YTD

57.14%

1 year

42.9%

All time high

8.25

Key Fundamentals

EPS 3 yr Growth

450.00%

EBITDA Margin

12.30%

Operating Cashflow

$44m

Free Cash Flow Return

21.90%

ROIC

10.30%

Interest Coverage

16.70

Quick Ratio

5.20

Other Data

Shares on Issue (Fully Dilluted)

309m

HALO Sector

Healthcare

Next Company Report Date

01-Sep-26

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

3.93

NAN Announcements

Latest Announcements

Date Announcements

26 August 25

Appendix 4E

×

Appendix 4E

26 August 25

2025 Corporate Governance Statement

×

2025 Corporate Governance Statement

26 August 25

Appendix 4G

×

Appendix 4G

26 August 25

2025 Sustainability Report

×

2025 Sustainability Report

26 August 25

2025 Annual Report

×

2025 Annual Report

26 August 25

2025 Full Year Financial Results

×

2025 Full Year Financial Results

26 August 25

2025 Full Year Results Investor Presentation

×

2025 Full Year Results Investor Presentation

07 August 25

FY25 Full Year Results webinar notification

×

FY25 Full Year Results webinar notification

06 August 25

US FDA clearance received for next generation trophon

×

US FDA clearance received for next generation trophon

25 July 25

Change in substantial holding

×

Change in substantial holding

24 July 25

Change in substantial holding

×

Change in substantial holding

23 July 25

Becoming a substantial holder

×

Becoming a substantial holder

14 July 25

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

07 July 25

Nanosonics launches trophon3 and trophon2 Plus software

×

Nanosonics launches trophon3 and trophon2 Plus software

02 July 25

Becoming a substantial holder

×

Becoming a substantial holder

26 June 25

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

25 June 25

Becoming a substantial holder

×

Becoming a substantial holder

18 June 25

Becoming a substantial holder from PNI

×

Becoming a substantial holder from PNI

16 June 25

Application for quotation of securities - NAN

×

Application for quotation of securities - NAN

16 June 25

Notification of cessation of securities - NAN

×

Notification of cessation of securities - NAN

21 May 25

Response to ASX Price Query

×

Response to ASX Price Query

05 May 25

Change of Director's Interest Notice

×

Change of Director's Interest Notice

31 March 25

Notification of cessation of securities - NAN

×

Notification of cessation of securities - NAN

25 March 25

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

25 March 25

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

24 March 25

Application for quotation of securities - NAN

×

Application for quotation of securities - NAN

NAN Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.07 0.04 0.07 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.06 0.04 0.07 Lock Lock Lock
     Growth % Lock Lock Lock Lock 432.3 -35.2 59.3 Lock Lock Lock
     PE X Lock Lock Lock Lock 87.9 78.2 73.7 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 55.5 48.0 46.7 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.10 0.06 0.11 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.06 0.07 0.11 Lock Lock Lock
     Growth % Lock Lock Lock Lock 336.6 -33.0 66.8 Lock Lock Lock
     Yield % Lock Lock Lock Lock 1.4 2.2 2.8 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.54 0.60 0.69 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.54 0.60 0.69 Lock Lock Lock
     Growth % Lock Lock Lock Lock 18.1 11.0 15.0 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 306 309 309 Lock Lock Lock
Basic m Lock Lock Lock Lock 301 303 303 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Income Statement
Sales $m Lock Lock Lock Lock 168 172 198 Lock Lock Lock
     Growth % Lock Lock Lock Lock 39.9 2.4 15.6 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 108 119 131 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 126 127 148 Lock Lock Lock
     Growth % Lock Lock Lock Lock 45.9 1.2 16.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock 75.0 74.1 74.6 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 25 26 25 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 25 16 24 Lock Lock Lock
     Growth % Lock Lock Lock Lock 285.6 -36.3 52.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock 15.0 9.3 12.3 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 7 8 8 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 18 8 16 Lock Lock Lock
     Growth % Lock Lock Lock Lock 2,172.6 -53.4 95.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock 10.7 4.9 8.3 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 22 13 22 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 2 0 2 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 20 13 21 Lock Lock Lock
     Growth % Lock Lock Lock Lock 431.3 -34.8 59.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock 11.9 7.6 10.4 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 23 23 44 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 4 3 9 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -4 -2 -9 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock -3 -3 -3 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 20 20 35 Lock Lock Lock
     Growth % Lock Lock Lock Lock 21,565.2 2.6 74.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.1 0.1 0.2 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 1 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 112 130 162 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 226 242 276 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 8 6 4 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -101 -120 -154 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 62 60 66 Lock Lock Lock
Equity $m Lock Lock Lock Lock 164 182 210 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 172 188 214 Lock Lock Lock
     Growth % Lock Lock Lock Lock 16.1 9.7 13.7 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 8.8 5.4 7.5 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 12.1 7.1 9.8 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 11.1 4.6 8.0 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 12.4 7.2 10.3 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 14.6 12.7 21.9 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Leverage
Interest Cover X Lock Lock Lock Lock 32.6 14.5 16.7 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -4.0 -7.5 -6.3 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -61.9 -66.0 -73.3 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 5.5 6.1 5.7 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 4.7 5.5 5.2 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 61.9 65.5 71.9 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 70.6 70.7 110.5 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 5.0 4.3 5.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 1.7 1.9 2.6 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 1.1 1.0 1.1 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 2.2 2.0 0.8 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.7 0.7 0.7 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.7 0.7 0.7 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 12.9 7.6 11.2 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 9.6 5.4 8.1 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 7.9 0.1 7.2 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 8.8 5.4 7.5 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.4 1.3 1.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 12.1 7.1 9.8 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 12.1 7.1 9.8 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 209.7 188.0 140.6 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 73.2 84.4 72.6 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 283.0 272.4 213.3 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 26.5 33.7 18.7 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 256.4 238.7 194.6 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

.0%

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

7.45%

Value ($M)

92

Prior Change

-0.10%

7 Day Change

N/A

1 Month Change

0.50%

3 Month Change

3.50%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

NAN Shortsell

Frequently Asked Questions

The current share price of Nanosonics Limited (NAN:ASX) is AU$4.47.
The 52-week high share price for Nanosonics Limited (NAN:ASX) is AU$5.18.
The 52-week low share price for Nanosonics Limited (NAN:ASX)? is AU$2.86.
The current TTM dividend payout for Nanosonics Limited (NAN:ASX) is 0.00.
Nanosonics Limited (NAN:ASX) does not pay a dividend.
Nanosonics Limited (NAN:ASX) has a franking level of 0.0%.
Nanosonics Limited (NAN:ASX) is classified in the Healthcare.
The current P/E ratio for Nanosonics Limited (NAN:ASX) is 73.70.
The current share price of Nanosonics Limited (NAN:ASX) is AU$4.47.
The 52-week high share price for Nanosonics Limited (NAN:ASX) is AU$5.18.
The 52-week low share price for Nanosonics Limited (NAN:ASX)? is AU$2.86.
The current TTM dividend payout for Nanosonics Limited (NAN:ASX) is 0.00.
Nanosonics Limited (NAN:ASX) does not pay a dividend.
Nanosonics Limited (NAN:ASX) has a franking level of 0.0%.
Nanosonics Limited (NAN:ASX) is classified in the Healthcare.
The current P/E ratio for Nanosonics Limited (NAN:ASX) is 73.70.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.